NDAORALTABLET
Approved
Apr 2003
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Mechanism of Action
CLINICAL PHARMACOLOGY Pharmacokinetics The pharmacokinetics of gemifloxacin are approximately linear over the dose range from 40 mg to 640 mg. There was minimal accumulation of gemifloxacin following multiple oral doses up to 640 mg a day for 7 days (mean accumulation <20%). Following repeat oral…
Indications (6)
infections caused by susceptible strains of the designated microorganisms in the conditions listed belowdevelopment of drug-resistant bacteriamaintain the effectiveness of FACTIVEother antibacterial drugsFACTIVE should be used only to treat infectionsstrongly suspected to be caused by susceptible bacteria